ResourcesVendorsBeckman Coulter250 S. Kraemer Blvd Brea, CA, USA 92822Latest from Beckman CoulterConcussionDanaher launches collaboration with Johns Hopkins University on TBI diagnosticsBy LabPulse.com staff writersDanaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.May 9, 2024CollaborationIllumina inks deal to sell Pillar Biosciences’ cancer assaysBy Nick Paul TaylorPillar, which has partnerships with Beckman Coulter Life Sciences and Labcorp, designed its NSCLC and CRC panel to run on the Illumina MiSeq Dx instrument. The instrument is a next-generation sequencing (NGS) platform for in vitro diagnostic testing.July 26, 2023ImmunoassaysBeckman Coulter analyzer developed 'from the ground up' to address IVD industry constraintsBy Leo O'ConnorAt a time of scarce resources, the system requires no daily maintenance and only 10 minutes weekly and monthly maintenance, said Dr. Pamela Christudoss of Christian Medical College, who evaluated the analyzer prior to its broad launch last week.May 23, 2023Business InsightsWeek in Review: Quest on detecting dementia | Roche routine mass-spec test | A Labcorp acquisitionBy Leo O'ConnorRoche Diagnostics will showcase technologies for lab automation, the serum work area, and molecular and point-of-care solutions at an industry event; it is also unveiling a prototype for the Cobas Mass Spec system.May 18, 2023Product LaunchBeckman Coulter Diagnostics announces global launch of immunoassay analyzerBy LabPulse.com staff writersThe analyzer can run up to 215 tests per hour per square meter and, according to Beckman Coulter Diagnostics, beta users attest to a feature that redefines their workday with no daily maintenance requirements.May 15, 2023Business InsightsDeclining COVID-19 test market may still reach $25M in 2023: ReportBy Bruce CarlsonDespite a decline in sales, COVID-19 is expected to represent one of the larger single-disease categories in IVD testing, according to Kalorama. Rapid testing, mostly antigen-based, will hold up the market while growth drops in lab-based PCR testing.April 28, 2023Business InsightsWeek in Review: IVD firms' base business growth | Quest’s ctDNA acquisition | A DNA Day interviewBy Leo O'ConnorCompanies continued to face tough comparisons with the year-ago quarter, when demand for COVID-19 testing was still high. Encouragingly, they are seeing strength in businesses other than COVID-19 testing.April 27, 2023CollaborationBeckman Coulter, Sciex collaborate on high-throughput screening workflowsBy LabPulse.com staff writersThe Sciex Echo MS system, which leverages acoustic ejection mass spectrometry, is now compatible with the Biomek and Echo liquid handler lines from Beckman Coulter Life Sciences.February 27, 2023Point-of-Care TestingBeckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic testBy LabPulse.com staff writersMeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.January 31, 2023Financial ResultsQuidelOrtho reports 54% rise in Q3 revenues, identifies additional cost synergies from business combinationBy Leo O'ConnorThe firm added that for the quarter ended October 2, its total supplemental combined revenue of $783.8 million decreased by 24%.November 3, 2022Business InsightsWeek in Review: Roche, Abbott, Quest, Danaher report financial results, provide perspectives on COVID-19 testing salesBy Leo O'ConnorOctober 21, 2022Financial ResultsDanaher Q3 diagnostics revenues rise 9%By LabPulse.com staff writersThird-quarter year-over-year core revenue growth within diagnostics was 14%, with Cepheid growing about 30%.October 20, 2022Mergers & AcquisitionsBeckman Coulter Diagnostics acquires AI clinical decision-support firm StoCasticBy LabPulse.com staff writersStoCastic has developed TriageGo, a triage decision-support tool that will be the cornerstone of Beckman Coulter's AI-enabled clinical decision support portfolio.October 11, 2022ConsumerBoosted by COVID-19 and cancer tests, IVD market reaches $127B: KaloramaBy Bruce CarlsonThat's the finding from Kalorama's market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition.August 25, 2022AgreementVideo from AACC: Beckman Coulter partners with ScopioBy Leo O'ConnorDr. Peter Soltani, senior vice president and general manager at Beckman Coulter, and Itai Hayut, cofounder and CEO of Scopio Labs, spoke to LabPulse.com and ScienceBoard.net about the partnership.July 31, 2022
